We observed a differential elevation of TNF-α (greater in TS COPD) and IL-1β (greater in BMS COPD) with a significant dose response relationship with severity of COPD, with a large increase in late stage COPD (GOLD IV). Here, TNF is linked to chronic obstructive pulmonary disease.